Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Susan, Shetterly"'
Publikováno v:
Journal of General Internal Medicine. 38:502-507
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::883626912135519f5dd5c1a43ed6d51b
https://doi.org/10.1007/s11606-022-07902-w
https://doi.org/10.1007/s11606-022-07902-w
Autor:
Emily Reeve, Elizabeth A Bayliss, Susan Shetterly, Mahesh Maiyani, Kathy S Gleason, Jonathan D Norton, Orla C Sheehan, Ariel R Green, Matthew L Maciejewski, Melanie Drace, Jennifer Sawyer, Cynthia M Boyd
Background people living with cognitive impairment commonly take multiple medications including potentially inappropriate medications (PIMs), which puts them at risk of medication related harms. Aims to explore willingness to have a medication depres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f411df8d3075637e0fdfe92a560120a0
https://hdl.handle.net/11541.2/32695
https://hdl.handle.net/11541.2/32695
Autor:
Brandon Ason, José W.A. van der Hoorn, Joyce Chan, Edward Lee, Elsbet J. Pieterman, Kathy Khanh Nguyen, Mei Di, Susan Shetterly, Jie Tang, Wen-Chen Yeh, Margrit Schwarz, J. Wouter Jukema, Rob Scott, Scott M. Wasserman, Hans M.G. Princen, Simon Jackson
Publikováno v:
Journal of Lipid Research, Vol 55, Iss 11, Pp 2370-2379 (2014)
LDL cholesterol (LDL-C) contributes to coronary heart disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9) increases LDL-C by inhibiting LDL-C clearance. The therapeutic potential for PCSK9 inhibitors is highlighted by the fact that PCSK9 l
Externí odkaz:
https://doaj.org/article/a47428822d15485fadea23f4fd960402
Publikováno v:
The Senior care pharmacist. 37(5)
Objective To study assessed adherence to 11 chronic medications and one medication class with high medical necessity in people with cognitive impairment (CIM) and identified clinical characteristics associated with nonadherence. Design This was a ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a84552bd0db87fa3eaab6886c9a8ade
https://pubmed.ncbi.nlm.nih.gov/35450561
https://pubmed.ncbi.nlm.nih.gov/35450561
Autor:
Brandon Ason, Joshua Dobroff, Khrystyna Platko, Susan Shetterly, Wadih Arap, Paul F. Lebeau, Jae Hyun Byun, Hanny Wassef, Simon Jackson, Richard C. Austin, Nabil G. Seidah, Michel Chrétien, Renata Pasqualini, Kevin Doyoon Won, Annik Prat, Guillaume Paré, William G. Richards, Ali Al-Hashimi, An Tang, Majambu Mbikay
Publikováno v:
J Clin Invest
Individuals harboring the loss-of-function (LOF) proprotein convertase subtilisin/kexin type 9 Gln152His variation (PCSK9(Q152H)) have low circulating low-density lipoprotein cholesterol levels and are therefore protected against cardiovascular disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3aed12ff8d783824b3ce2daf33b5682
https://doi.org/10.1172/jci128650
https://doi.org/10.1172/jci128650
Autor:
Franziska Jost, Bruce A. Macher, Ronald Knegtel, Susan R. Watson, Eric H. Holmes, Susan Shetterly
Publikováno v:
Journal of Biological Chemistry. 282:24882-24892
Fucose transfer from GDP-fucose to GlcNAc residues of the sialylated polylactosamine acceptor NeuAcalpha2-3Galbeta1-4Glc-NAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta1-ceramide leads to two isomeric monofucosyl antigens, VIM2 and sialyl-Le(x). H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d20d4b5000f563d3b05bb1d57fd12026
https://doi.org/10.1074/jbc.m702395200
https://doi.org/10.1074/jbc.m702395200
Autor:
Bei Shan, Simon Jackson, Qiang Liu, William G. Romanow, Derek E. Piper, Nigel Walker, Stephen T. Thibault, Susan Shetterly
Publikováno v:
Structure. 15(5):545-552
SummaryProprotein convertase subtilisin kexin type 9 (PCSK9) has been shown to be involved in the regulation of extracellular levels of the low-density lipoprotien receptor (LDLR). Although PCSK9 is a subtilase, it has not been shown to degrade the L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72659780d8857c7e3556d36c59b50801
Autor:
Debra P. Ritzwoller, Carolyn Buxton Bridges, Susan Shetterly, Kristi Yamasaki, Margarette Kolczak, Eric K. France
Publikováno v:
Pediatrics. 116:153-159
Objective. To evaluate the effectiveness of 1 and 2 doses of the 2003–2004 influenza vaccine in preventing medically attended influenza-like illness (ILI) among children 6 to 23 months and 6 months to 8 years of age. Design and Methods. Outpatient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f378ddfa2dcdd9d6eaae6a35e55b13
https://doi.org/10.1542/peds.2005-0049
https://doi.org/10.1542/peds.2005-0049
Autor:
Larry A Allen, David J Magid, Susan Shetterly, Pamela N Peterson, David W Brand, David B Bekelman, Christina L Clarke, John A Spertus, Frederick A Masoudi
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 6
Background: Existing heart failure (HF) risk models have only moderate performance for adverse outcomes. Whether serial health status measurements can improve risk stratification is unknown. Methods: In 2007 and again in 2008, we administered Kansas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f6eaa4e7c8be6583a99ad8c713dd5f
https://doi.org/10.1161/circoutcomes.6.suppl_1.a141
https://doi.org/10.1161/circoutcomes.6.suppl_1.a141
Publikováno v:
Pharmacoepidemiology and drug safety. 23(8)
Assessing the safety and effectiveness of medical products with observational electronic medical record data is challenging when the treatment is time-varying. The objective of this paper is to develop a Cox model stratified by event times with stabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::799cadff0e69837a4a768e40647e816c
https://pubmed.ncbi.nlm.nih.gov/24596337
https://pubmed.ncbi.nlm.nih.gov/24596337